Nasdaq Technology

Angie Ruan, senior vice president of Global Technology at Nasdaq, shares her advice to young professionals who aspire to work in the capital markets.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Paypal (PYPL), which belongs to the Zacks Internet - Software industry, could be a great candidate to consider.

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Juniper Networks (JNPR). This company, which is in the Zacks Wireless Equipment industry

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Range Resources (RRC), which belongs to the Zacks Oil and Gas - Exploration and Production - United States industr

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Take-Two Interactive (TTWO), which belongs to the Zacks Toys - Games - Hobbies industry.

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Phillips 66 (PSX), which belongs to the Zacks Oil and Gas - Refining and Marketing industry.

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Square (SQ). This company, which is in the Zacks Internet - Software industry, shows pot

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Amazon (AMZN). This company, which is in the Zacks Internet - Commerce industry, shows p

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Credit Acceptance (CACC). This company, which is in the Zacks Financial - Consumer Loans

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Microsoft (MSFT), which belongs to the Zacks Computer - Software industry, could be a great candidate to consider.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Starbucks (SBUX), which belongs to the Zacks Retail - Restaurants industry, could be a great candidate to consider

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advanta

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advanta

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advanta

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advanta

ProQR Therapeutics N.V. PRQR announced that it has started dosing patients in the phase II/III study – ILLUMINATE – evaluating its RNA-based candidate sepofarsen (QR-110) for an eye disorder, Leber’s congenital amaurosis 10 (LCA10).

Shares of Achaogen, Inc. AKAO plunged almost 65% after the company announced that it has filed a voluntary petition under Chapter 11 of the Bankruptcy Code in a district court.

Alnylam Pharmaceuticals, Inc. ALNY announced that it has initiated ILLUMINATE-B, a global phase III pediatric study on its investigational, subcutaneously administered RNAi therapeutic, lumasiran. The drug is being evaluated for the treatment of primary hyp

Stryker Corporation SYK recently announced the U.S. launch of its newest defibrillation solution, the LIFEPAK CR2 automated external defibrillator ("AED") with LIFELINKcentral AED program manager. This development came on the heels of the company receipt of FDA&